Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK

被引：0
作者：
Heide A. Stirnadel-Farrant
Sarowar M. Golam
Barbara Naisbett-Groet
Danny Gibson
Julia Langham
Sue Langham
Mihail Samnaliev
机构：
[1] AstraZeneca,BioPharmaceuticals Medical
[2] AstraZeneca,BioPharmaceuticals Medical
[3] Health Economics,Epidemiology Group
[4] AstraZeneca,Health Economics Group
[5] Maverex Limited,Statistical Group
[6] Maverex Limited,Oncology Business Unit, AstraZeneca
[7] Maverex Limited,undefined
[8] AstraZeneca Academy House,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
Adverse effect; Corticosteroid; Cost; Healthcare resource use; National Health Service; Systemic lupus erythematosus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1167 / 1182
页数：15
相关论文
共 213 条
[81]  
Friedel H(undefined)undefined undefined undefined undefined-undefined
[82]  
Garal-Pantaler E(undefined)undefined undefined undefined undefined-undefined
[83]  
Pignot M(undefined)undefined undefined undefined undefined-undefined
[84]  
Wang X(undefined)undefined undefined undefined undefined-undefined
[85]  
Nab H(undefined)undefined undefined undefined undefined-undefined
[86]  
Petri M(undefined)undefined undefined undefined undefined-undefined
[87]  
Bechtel B(undefined)undefined undefined undefined undefined-undefined
[88]  
Dennis G(undefined)undefined undefined undefined undefined-undefined
[89]  
Shah M(undefined)undefined undefined undefined undefined-undefined
[90]  
McLaughlin T(undefined)undefined undefined undefined undefined-undefined
45678910111213